John P. McVicar

Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.

Kenneth E. Thummel, Danny D. Shen, Terry Podoll et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 356 citations

First-pass metabolism of midazolam by the human intestine*

Mary F. Paine, Danny D. Shen, Kent L. Kunze et al. · Clinical Pharmacology & Therapeutics · 1996 · 304 citations

First-pass Metabolism, Gastrointestinal Pharmacology, Gastroenterology +17

Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.

Kenneth E. Thummel, Danny D. Shen, Terry Podoll et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 223 citations

De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation

Suk Seo, Kalyani Maganti, Manjit Khehra et al. · Liver Transplantation · 2006 · 173 citations · Full text

Metabolic Associated Steatohepatitis, Hepatology, Metabolic Associated Steatotic Liver Disease +15

Endoscopic management of biliary strictures in liver transplant recipients: effect on patient and graft survival

Rafat Rizk, John P. McVicar, Mary J. Emond et al. · Gastrointestinal Endoscopy · 1998 · 155 citations

Transplantation Surgery, Urology, Liver Transplant Recipients +10